REDHILL BIOPHARMA LTD-SP ADR (RDHL)
US7574682024 - ADR
2.2 -0.12 (-5.17%)
RedHill Provides R&D Update
RedHill has elected to terminate RHB-204's U.S. Phase 3 study for Non-tuberculosis Mycobacteria (NTM) disease due to low accrual rate and plans to shift...
RedHill Biopharma Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has received...
RedHill's RHB-102 (BEKINDA®) and Opaganib Granted New Patents in Oncology Setting
/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the granting of two...
RedHill Biopharma Announces Q4/22 & Full-Year 2022 Results and Operational Highlights
Having extinguished all debt and significantly reduced cost-base, RedHill is now focused on late-stage pipeline advancement, in collaboration with U.S. and...
RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it received...
RedHill Biopharma Announces Closing of $6 Million Registered Direct Offering
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has closed...
RedHill Biopharma Announces $6 Million Registered Direct Offering
/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...
RedHill Biopharma announces plan to implement ADS ratio change (NASDAQ:RDHL)
RedHill Biopharma (RDHL) plans to change the ADS ratio to its non-traded ordinary shares, from one ADS representing ten ordinary shares to one ADS representing four...
RedHill Biopharma Announces Plan to Implement ADS Ratio Change
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it plans to...
RedHill Biopharma Announces Definitive Agreement for Up To $6 Million Private Placement with a Single Investor
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced agreement, with a...
RedHill Biopharma and HealthCare Royalty Agree to Extinguish All RedHill's Debt Obligations in Exchange for Movantik®
/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the extinguishment...
Why Is GeneDx (WGS) Stock Down 8% Today?
GeneDx (WGS) stock is taking a beating on Friday after the company revealed a $150 million proposed public stock offering.
Why Is ContraFect (CFRX) Stock Down 23% Today?
ContraFect (CFRX) stock is falling on Friday after the company provided an update on its potential delisting from the Nasdaq Capital Market.
Why Is Akanda (AKAN) Stock Up 31% Today?
Akanda (AKAN) stock is on the rise Friday as the company's shares continue a rally that started yesterday following an FDA update.
Why Is Redhill Biopharma (RDHL) Stock Up 32% Today?
Redhill Biopharma (RDHL) stock is rocketing higher on Friday after getting positive patent news from the USPTO for RHB-204.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
RedHill (NASDAQ:RDHL) COVID-19 antiviral data published in peer-reviewed journal
RedHill Biopharma (RDHL) said results from its phase two study of RHB-107 for COVID-19 was published in the peer-reviewed International Journal of Infectious Diseases. Read more here.
RedHill Biopharma Closes $8.0 Million Underwritten Public Offering
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing of an...
RedHill's Aemcolo granted FDA 5-year exclusivity extension (NASDAQ:RDHL)
RedHill Biopharma (RDHL) is trading 1.6% higher after the company said the U.S